| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $16.4M | -31.4% |
| SG&A Expense | $21.0M | +54.8% |
| Income Tax | $0 | — |
| Net Income | -$112.7M | -203.4% |
| EPS (Basic) | -$67.99 | -3807.5% |
| EPS (Diluted) | -$68.16 | -3817.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.8M | -45.8% |
| Current Assets | $30.2M | -46.7% |
| Total Assets | $30.2M | -46.9% |
| Current Liabilities | $3.2M | -56.2% |
| Total Liabilities | $3.2M | -56.2% |
| Stockholders' Equity | $25.6M | -48.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.0M | +33.6% |
| Capital Expenditures | $26K | — |
| Investing Cash Flow | -$26K | — |
| Financing Cash Flow | $683K | -60.9% |
| Free Cash Flow | -$25.0M | — |